União Europeia - esloveno - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - zdravila za obstruktivne pljučne bolezni, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

União Europeia - esloveno - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - zdravila za obstruktivne pljučne bolezni, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

União Europeia - esloveno - EMA (European Medicines Agency)

teva b.v. - salmeterol xinafoate, fluticasone propionat - astma - zdravila za obstruktivne pljučne bolezni, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

União Europeia - esloveno - EMA (European Medicines Agency)

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - zdravila za obstruktivne pljučne bolezni, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

merck sharp & dohme, d.o.o. - rizatriptan - peroralni liofilizat - rizatriptan 10 mg / 1 prašek - rizatriptan

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

merck sharp & dohme, d.o.o. - rizatriptan - tableta - rizatriptan 10 mg / 1 tableta - rizatriptan

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

merck sharp & dohme, d.o.o. - rizatriptan - peroralni liofilizat - rizatriptan 5 mg / 1 prašek - rizatriptan

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

merck sharp & dohme, d.o.o. - rizatriptan - tableta - rizatriptan 5 mg / 1 tableta - rizatriptan

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bms Češka - cefepim - prašek za raztopino za injiciranje - cefepim 1 g / 1 viala - cefepim

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bms Češka - cefepim - prašek za raztopino za injiciranje - cefepim 2 g / 1 viala - cefepim